Cyclacel Pharmaceuticals, Inc.
看多

CYCC Oversold Previously, Now Everyone's Buying

68
It gapped down in the past because they dropped one of their studies but the company has many other products in development. There are messages that the float has been bought up and funds and insiders are buying heavily for some event.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。